Get started
Author

Christopher McMaster

Observed names: C. McMaster, C. Mcmaster, Chris McMaster, Christopher Mcmaster, Christopher R McMaster, Christopher R. McMaster, McMaster, Christopher R.
Observed institutions: The University of Melbourne, Canadian Institutes of Health Research, Austin Hospital, Monash Health, Heidelberg Repatriation Hospital, Austin Health, Monash University, Hacettepe University
ORCID: 0000-0003-2432-5451
Observed ORCID: 0000-0003-2432-5451
OpenAlex ID: A5019189705
Waiting for JAK inhibitor safety data
2022 · Tue Wenzel Kragstrup, Bente Glintborg, et al. · RMD Open · 91
PDF
Artificial Intelligence and Deep Learning for Rheumatologists
2022 · Christopher McMaster, Alix Bird, et al. · Arthritis & Rheumatology · 82
PDF
Developing a deep learning natural language processing algorithm for automated reporting of adverse drug reactions
2022 · Christopher McMaster, Julia Chan, et al. · Journal of Biomedical Informatics · 58
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
2023 · Victor Yang, Tue W. Kragstrup, et al. · Drug Safety · 57
PDF
Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity
2020 · Claire E. Owen, Aurora M. T. Poon, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 48
Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint
2022 · Alix Bird, Lauren Oakden-Rayner, et al. · Arthritis Research & Therapy · 47
PDF
A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding
2019 · Christopher McMaster, David Liew, et al. · Drug Safety · 38
Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas
2023 · Claire E Owen, Aurora M T Poon, et al. · Rheumatology Advances in Practice · 29
PDF
Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica
2020 · Claire E. Owen, Christopher McMaster, et al. · International Journal of Rheumatic Diseases · 17
Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culture
2023 · Pallavi Shamdasani, David F L Liew, et al. · Rheumatology Advances in Practice · 9
PDF
The complexity of funding rare disease research: an IRDiRC assessment of the landscape
2024 · Lucia Monaco, Mary Catherine V. Letinturier, et al. · Rare Disease and Orphan Drugs Journal · 8
PDF
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort
2022 · Christopher McMaster, David F L Liew, et al. · Lara D. Veeken · 6
Comment on: Deep learning algorithms for magnetic resonance imaging of inflammatory sacroiliitis in axial spondyloarthritis
2022 · Christopher McMaster, David F L Liew, et al. · Lara D. Veeken · 5
Promoting resilience to weather‐related and seasonal provocations to health in people with multimorbid heart disease: a prospective pragmatic, randomised trial
2025 · Simon Stewart, Sheila K Patel, et al. · The Medical Journal of Australia · 3
PDF
Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic 18F-FDG PET/CT findings
2025 · Emily Martin, Christopher R. McMaster, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2
Clinical evaluation is critical for the implementation of artificial intelligence in health care: comment on the article by Mickley et al
2024 · Alix Bird, Christopher McMaster, et al. · Arthritis Care & Research · 2
PDF
Better diagnostic tools needed for biopsy-negative giant cell arteritis
2022 · Victor Yang, Christopher McMaster, et al. · The Lancet Rheumatology · 2
Better pharmacovigilance through artificial intelligence: What is needed to make this a reality?
2022 · Julia TH Chan, David FL Liew, et al. · Health Policy and Technology · 1
Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate
2021 · Victor Yang, Christopher McMaster, et al. · Lara D. Veeken · 1
THU0616 Elevated thyroid stimulating hormone as a potential biomarker for rheumatic immune-related adverse events following pd-1 inhibitor therapy
2018 · D.F.L. Liew, J.L.Y. Leung, et al. · Annals of the Rheumatic Diseases · 1
PDF
Design and implementation of an electronic opioid management plan to support consistent communication of opioid analgesia prescribing intentions to patients and general practitioners
2023 · Elizabeth Su, Parnaz Aminian, et al. · Journal of Pharmacy Practice and Research
PDF
Op0194 Generalized Immune Activation in Structures Related to Pmr or Gca on Pet/ct Assessment Does Not Occur in Immune Checkpoint Inhibitor-treated Patients Who Do Not Go on to Develop Rheumatic Immune-related Adverse Events
2021 · D. Liew, A. Poon, et al. · Annals of the Rheumatic Diseases
PDF
Fibromyalgia, "fibromyalgianess", and Fatigue Are Common Six Months Following Covid-19 Infection
2021 · Evgenia Martin, Hari Wimaleswaran, et al. · Internal Medicine Journal
Sat0279 Factors Predictive of Positive Temporal Artery Biopsy in Two Australian Cohorts
2020 · V. Yang, B. Sutu, et al. · Annals of the Rheumatic Diseases
PDF
Neutrophil to Lymphocyte Ratio Predicts Glucocorticoid Resistance in Polymyalgia Rheumatica: A Prospective Study
2020 · Claire Owen, Christopher McMaster, et al.
PDF
Works count: 42
Citation count: 506
H-index: 9
I10-index: 9
Year
Topic
Type